TaiwanJ Pharmaceuticals Co., Ltd.
TWO: 6549.TWO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taipei Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Hung-Chang Yuan
- Employees
- 13
- Headquarters
- Zhubei, Taiwan
- IPO year
- 2015
- Market cap
- NT$653.8M
- Website
- https://www.taiwanj.com
Loading 6549…
Loading profile data…Frequently asked questions about 6549
What does TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) do?
TaiwanJ Pharmaceuticals Co., Ltd., a specialty pharmaceutical company, develops and commercializes small molecules for chronic organ inflammation of metabolic, autoimmune, and infectious etiologies in Taiwan. The company also develops JKB-122 and JKB-121; and novel chemical entities for therapy to address chronic liver diseases and allergy/asthm...
Where does 6549.TWO trade?
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) trades on the Taipei Exchange.
What sector is 6549.TWO in?
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of TaiwanJ Pharmaceuticals Co., Ltd.?
Hung-Chang Yuan is the chief executive officer of TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO).
Where is TaiwanJ Pharmaceuticals Co., Ltd. headquartered?
TaiwanJ Pharmaceuticals Co., Ltd. is headquartered in Taiwan.
Does 6549.TWO pay a dividend?
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6549.TWO go public?
TaiwanJ Pharmaceuticals Co., Ltd. (6549.TWO) completed its initial public offering in 2015.